CONVERT TO A BUPRENORPHINE TREATMENT

The conversion to buprenorphine treatment is a crucial step for individuals facing the challenges and drawbacks of Methadone therapy. Although Methadone has long been used for opioid (fentanyl, heroin, oxycodone) addiction treatment, it comes with complications.
Patients often experience prolonged withdrawal symptoms, potential misuse, and side effects that hinder recovery. In contrast, buprenorphine offers advantages as a partial agonist at opioid receptors, alleviating withdrawal symptoms and cravings while reducing overdose risk with its ceiling effect. During the transition from Methadone to buprenorphine, careful monitoring and dosage adjustments are essential for safety and efficacy.
Buprenorphine’s flexible administration—available as sublingual tablets or films—provides greater convenience, aligning with patients’ lifestyle needs. By switching to buprenorphine, individuals may find renewed hope in their recovery, leading them toward a more manageable and healthier path. Unlike Methadone, which requires clinic visits that disrupt daily life and work schedules, buprenorphine is self-administered.
Note: Buprenorphine helps protect against Neo-Natal Abstinence Syndrome (NAS).